Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 3 (2007), Issue 11 (November)

1. Drug prescribing pattern at the medical outpatient clinic of a tertiary hospital in southwestern Nigeria.
   Pharmacoepidemiol Drug Saf, 16(11): 1244-9. [Abstract] [Full-text]
2. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
   Curr Med Res Opin, 23(11): 2805-14. [Abstract] [Full-text]
3. Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective.
   Curr Med Res Opin, 23(11): 2867-75. [Abstract] [Full-text]
4. The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations.
   Curr Med Res Opin, 23(11): 2887-95. [Abstract] [Full-text]
5. Medication Administration Discrepancies Persist Despite Electronic Ordering.
   J Am Med Inform Assoc, 14(6): 756-764. [Abstract] [Full-text]
6. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.
   J Allergy Clin Immunol, 120(5): 1153-9. [Abstract] [Full-text]
7. Experience with linezolid therapy in children with osteoarticular infections.
   Pediatr Infect Dis J, 26(11): 985-8. [Abstract] [Full-text]
8. Pharmacist privileging in a health system: Report of the Qualified Provider Model Ad Hoc Committee.
   Am J Health Syst Pharm, 64(22): 2373-81. [Abstract] [Full-text]
9. Assessing the performance, practices and roles of drug sellers/dispensers and mothers'/guardians' behaviour for common childhood conditions in Kibaha district, Tanzania.
   Trop Doct, 37(4): 197-201. [Abstract] [Full-text]
10. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Eur J Clin Pharmacol, 63(12): 1115-21. [Abstract] [Full-text]
11. Beliefs about medicines and self-reported adherence among pharmacy clients.
    Patient Educ Couns, 69(1): 158-64. [Abstract] [Full-text]
12. Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia.
    BJOG, 114(12): 1516-21. [Abstract] [Full-text]
13. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
    J Public Health (Oxf), 29(4): 350-7. [Abstract] [Full-text]
14. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
    Health Policy Plan, 22(6): 427-35. [Abstract] [Full-text]
15. Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin?
    Eur J Cancer, 43(17): 2580-9. [Abstract] [Full-text]
16. Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort.
    Cancer Epidemiol Biomarkers Prev, 16(11): 2218-25. [Abstract] [Full-text]
17. Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care.
    Pharm World Sci. [Abstract] [Full-text]
18. Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings.
    Am J Med Qual, 22(6): 445-56. [Abstract] [Full-text]
19. Comorbidities play a larger role in predicting health-related quality of life compared to having an ostomy.
    Am J Surg, 194(6): 774-9; discussion 779. [Abstract] [Full-text]
20. Health providers' competence in the management of reproductive tract infections in Vientiane, Lao People's Democratic Republic.
    Int J STD AIDS, 18(11): 774-81. [Abstract] [Full-text]
21. Educating student pharmacists about herbal medicines: faculty-librarian collaboration.
    Health Info Libr J, 24(4): 267-73. [Abstract] [Full-text]
22. A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004).
    Parkinsonism Relat Disord, 13(8): 500-4. [Abstract] [Full-text]
23. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
    J Clin Pharm Ther, 32(6): 625-32. [Abstract] [Full-text]
24. Survival in end stage renal disease: calcium carbonate vs. sevelamer.
    J Clin Pharm Ther, 32(6): 617-24. [Abstract] [Full-text]
25. Evaluation of quality of hydrogen peroxide-based antiseptic solutions available in Dar es Salaam, Tanzania.
    J Clin Pharm Ther, 32(6): 613-6. [Abstract] [Full-text]
26. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period.
    J Clin Pharm Ther, 32(6): 603-11. [Abstract] [Full-text]
27. Pharmacist prescribing in the UK - a literature review of current practice and research.
    J Clin Pharm Ther, 32(6): 545-56. [Abstract] [Full-text]
28. Evaluation of pharmacist clinical interventions in a Dutch hospital setting.
    Pharm World Sci, 30(1): 31-8. [Abstract] [Full-text]
29. Medication use and disease management of type 2 diabetic flemish patients.
    Pharm World Sci, 30(1): 51-6. [Abstract] [Full-text]
30. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Pharm World Sci, 30(1): 57-64. [Abstract] [Full-text]
31. When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making.
    Pharm World Sci, 30(1): 3-8. [Abstract] [Full-text]
32. Self-medication patterns in amman, jordan.
    Pharm World Sci, 30(1): 24-30. [Abstract] [Full-text]
33. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines.
    Pharm World Sci, 30(1): 17-23. [Abstract] [Full-text]
34. Documenting pharmacist's clinical interventions in New Zealand hospitals.
    Pharm World Sci, 30(1): 99-106. [Abstract] [Full-text]
35. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.
    Pharm World Sci, 30(1): 120-7. [Abstract] [Full-text]
36. Developing consensus around the pharmaceutical public health competencies for community pharmacists in Scotland.
    Pharm World Sci, 30(1): 111-9. [Abstract] [Full-text]
37. Effect of pharmaceutical care programme on blood pressure and quality of life in a nigerian pharmacy.
    Pharm World Sci, 30(1): 107-10. [Abstract] [Full-text]
38. Intrathecal drug therapy for long-term pain management.
    Am J Health Syst Pharm, 64(23): 2447-61. [Abstract] [Full-text]
39. Pharmaceutical care in community pharmacies: practice and research in Peru.
    Ann Pharmacother, 41(12): 2032-7. [Abstract] [Full-text]
40. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention.
    Ann Pharmacother, 41(12): 1979-85. [Abstract] [Full-text]
41. Impact of patient and plan design factors on switching to preferred statin therapy.
    Ann Pharmacother, 41(12): 1946-53. [Abstract] [Full-text]
42. Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies.
    Ann Pharmacother, 41(12): 2024-31. [Abstract] [Full-text]
43. Patient evaluation of a community pharmacy medications management service.
    Ann Pharmacother, 41(12): 1962-70. [Abstract] [Full-text]
44. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
    J Am Pharm Assoc (2003), 47(6): 747-55. [Abstract] [Full-text]
45. Factors affecting pharmacists' pediatric asthma counseling.
    J Am Pharm Assoc (2003), 47(6): 737-46. [Abstract] [Full-text]
46. Consumer expectations of nonprescription medications according to location of sale.
    J Am Pharm Assoc (2003), 47(6): 729-36. [Abstract] [Full-text]
47. Evaluation of calcium and vitamin D supplementation in bisphosphonate therapy.
    J Am Pharm Assoc (2003), 47(6): 725-8. [Abstract] [Full-text]
48. Student pharmacist knowledge and attitudes regarding oral emergency contraception.
    J Am Pharm Assoc (2003), 47(6): 711-6. [Abstract] [Full-text]
49. Pharmacy access to emergency contraception: Perspectives of pharmacists at a chain pharmacy in San Francisco.
    J Am Pharm Assoc (2003), 47(6): 702-10. [Abstract] [Full-text]
50. Earlier warning: A multi-indicator approach to monitoring trends in the illicit use of medicines.
    Int J Drug Policy. [Abstract] [Full-text]
51. Non-serotonin anti-depressant actions: Direct ion channel modulation by SSRIs and the concept of single agent poly-pharmacy.
    Med Hypotheses. [Abstract] [Full-text]
52. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Drug Alcohol Rev, 27(1): 47-53. [Abstract] [Full-text]
53. Universities preparing health professionals for the 21st century: Can something new come out of the traditional establishment?
    J Interprof Care, 21(6): 633-44. [Abstract] [Full-text]
54. Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages.
    Nat Clin Pract Rheumatol, 3(12): 725-32. [Abstract] [Full-text]
55. Evaluation of a Continuous Epidural Analgesia Program for Postoperative Pain in Children.
    Pain Manag Nurs, 8(4): 146-155. [Abstract] [Full-text]
56. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
    Arch Intern Med, 167(21): 2317-22. [Abstract] [Full-text]
57. Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?
    BMC Cardiovasc Disord, 7(1): 37. [Abstract] [Full-text]
58. Impact of Previous Statin and Angiotensin II Receptor Blocker Use on Mortality in Patients Hospitalized with Sepsis.
    Pharmacotherapy, 27(12): 1619-26. [Abstract] [Full-text]
59. Dispensing of antibiotics, antitussives and mucolytics to asthma patients: A pharmacy-based observational survey.
    Respir Med, 102(1): 57-63. [Abstract] [Full-text]
60. Effect of Increased Copayments on Pharmacy Use in the Department of Veterans Affairs.
    Med Care, 45(11): 1090-1097. [Abstract] [Full-text]
61. Selecting process quality indicators for the integrated care of vulnerable older adults affected by cognitive impairment or dementia.
    BMC Health Serv Res, 7(1): 195. [Abstract] [Full-text]

© 2005-2008 Pharmacy Research Today. All Rights Reserved.